Literature DB >> 31081031

Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.

Catiana Dudiuk1,2, Indira Berrio3,4, Florencia Leonardelli1,2, Soraya Morales-Lopez5,6, Laura Theill1, Daiana Macedo1,2, José Yesid-Rodriguez7, Soraya Salcedo8, Adriana Marin8, Soledad Gamarra1, Guillermo Garcia-Effron1,2.   

Abstract

BACKGROUND: Candida auris is an emerging MDR pathogen. It shows reduced susceptibility to azole drugs and, in some strains, high amphotericin B MICs have been described. For these reasons, echinocandins were proposed as first-line treatment for C. auris infections. However, information on how echinocandins and amphotericin B act against this species is lacking.
OBJECTIVES: Our aim was to establish the killing kinetics of anidulafungin, caspofungin and amphotericin B against C. auris by time-kill methodology and to determine if these antifungals behave as fungicidal or fungistatic agents against this species.
METHODS: The susceptibility of 50 C. auris strains was studied. Nine strains were selected (based on echinocandin MICs) to be further studied. Minimal fungicidal concentrations, in vitro dose-response and time-kill patterns were determined.
RESULTS: Echinocandins showed lower MIC values than amphotericin B (geometric mean of 0.12 and 0.94 mg/L, respectively). Anidulafungin and caspofungin showed no fungicidal activity at any concentration (maximum log decreases in cfu/mL between 1.34 and 2.22). On the other hand, amphotericin B showed fungicidal activity, but at high concentrations (≥2.00 mg/L). In addition, the tested polyene was faster than echinocandins at killing 50% of the initial inoculum (0.92 versus >8.00 h, respectively).
CONCLUSIONS: Amphotericin B was the only agent regarded as fungicidal against C. auris. Moreover, C. auris should be considered tolerant to caspofungin and anidulafungin considering that their MFC:MIC ratios were mostly ≥32 and that after 6 h of incubation the starting inoculum was not reduced in >90%.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31081031     DOI: 10.1093/jac/dkz178

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades.

Authors:  Zoltán Papp; Andrew M Borman; Lajos Forgács; Renátó Kovács; Zoltán Tóth; Chiu Chun-Ju; Gábor Kardos; Béla Juhász; Judit Szilvássy; László Majoros
Journal:  Pathogens       Date:  2021-08-06

2.  In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.

Authors:  Lajos Forgács; Andrew M Borman; Renátó Kovács; Dávid Balázsi; Zoltán Tóth; Bence Balázs; Chiu Chun-Ju; Gábor Kardos; Ilona Kovacs; László Majoros
Journal:  J Fungi (Basel)       Date:  2022-05-11

Review 3.  Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris.

Authors:  Ryan Kean; Gordon Ramage
Journal:  mSphere       Date:  2019-07-31       Impact factor: 4.389

4.  Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.

Authors:  Zoltán Tóth; Lajos Forgács; Tamás Kardos; Renátó Kovács; Jeffrey B Locke; Gábor Kardos; Fruzsina Nagy; Andrew M Borman; Awid Adnan; László Majoros
Journal:  J Fungi (Basel)       Date:  2020-08-17

Review 5.  Rezafungin-Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins.

Authors:  Guillermo Garcia-Effron
Journal:  J Fungi (Basel)       Date:  2020-11-01

6.  Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.

Authors:  Renátó Kovács; Zoltán Tóth; Jeffrey B Locke; Lajos Forgács; Gábor Kardos; Fruzsina Nagy; Andrew M Borman; László Majoros
Journal:  Microorganisms       Date:  2021-04-16

7.  Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris Using an Inkjet Printer-Assisted Method.

Authors:  Thea Brennan-Krohn; Liam Friar; Sarah Ditelberg; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

8.  In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris.

Authors:  Unai Caballero; Sarah Kim; Elena Eraso; Guillermo Quindós; Valvanera Vozmediano; Stephan Schmidt; Nerea Jauregizar
Journal:  Antibiotics (Basel)       Date:  2021-03-28

9.  Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris.

Authors:  Elisabetta de Alteriis; Angela Maione; Annarita Falanga; Rosa Bellavita; Stefania Galdiero; Luisa Albarano; Maria Michela Salvatore; Emilia Galdiero; Marco Guida
Journal:  Antibiotics (Basel)       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.